改良悬雍垂腭咽成形术治疗阻塞性睡眠呼吸暂停的8年随访
结果显示呼吸暂停低通气指数(AHI)较基线显著下降但较2年随访明显回升,日间嗜睡持续改善,基线超重及体重指数(BMI)增加预示长期呼吸结局较差。
要点
- 改良UPPP对部分OSA患者有长期疗效,但AHI改善随时间减退。
- 日间嗜睡在8年随访时仍较基线显著改善。
- 基线超重及随访期间BMI增加预示长期呼吸结局较差。
核心结论
- 改良UPPP对经选择的OSA患者是有效的长期治疗,但对AHI的疗效随时间下降,日间嗜睡长期仍改善。
主要发现
- 基线至8年随访AHI平均下降14.0次/小时(52.9降至38.9),降幅27%(P < .001)。
- 2年至8年随访AHI平均升高14.7次/小时(24.2升至38.9),升幅61%(P < .0001)。
- 基线超重者8年随访AHI较正常体重者高22.9次(P = .015)。
- 基线至8年随访BMI每增加1 kg/m2,预测AHI平均增加3.8次/小时(P = .015)。
- 基线至8年随访ESS中位下降7(13.0降至6.0),降幅54%(P < .0001);2年至8年ESS中位升高1.0(5.0升至6.0),差异无统计学意义。
关键数值与推荐
- 8年随访失访率为28%。
- 体重正常与超重的界定及回归模型细节原文未详述。
临床怎么用
- 对经选择的OSA患者,改良UPPP可作为长期治疗选项,但需监测AHI随时间的回升。
- 术后长期管理应重视体重控制,基线超重及BMI增加提示呼吸结局可能变差。
- 日间嗜睡改善可在长期随访中维持,可作为疗效评价的补充指标。
局限性
- 8年随访失访率达28%。
- 为单臂前瞻性干预研究,无随机对照。
- 证据等级为3级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether modified uvulopalatopharyngoplasty (UPPP) for treatment of obstructive sleep apnea (OSA) remained effective after 8 years. METHODS: Prospective intervention study. Sixty-five patients with OSA were offered re-evaluation with polysomnography and the Epworth Sleepiness Scale (ESS) 8 years after UPPP. Results were compared with baseline and with a previous 2-year follow-up. Baseline predictors were analyzed with regression analyses. RESULTS: The dropout rate at the 8-year follow-up was 28%. The mean decrease in apnea-hypopnea index (AHI) between baseline and the 8-year follow-up was significant, 14.0 events/hour (from 52.9 to 38.9), 27% (P < .001). The mean increase in AHI between the 2-year and the 8-year follow-up was significant, 14.7 events/hour (from 24.2 to 38.9), 61% (P < .0001). Overweight at baseline predicted an AHI at the 8-year follow-up that was 22.9 events higher compared to patients with normal weight (P = .015). An increase in body mass index (BMI) of 1 kg/m2 between baseline and the 8-year follow-up predicted a mean AHI increase of 3.8 events/hour (P = .015). The median decrease in ESS between baseline and the 8-year follow-up was significant, 7 (from 13.0 to 6.0), 54% (P < .0001). The median increase in ESS between the 2-year and the 8-year follow-up was not significant, 1.0 (from 5.0 to 6.0), 20%. CONCLUSION: Modified UPPP was effective as a long-term treatment for OSA in selected patients, although the effect on AHI decreased over time. Daytime sleepiness remained improved even in the long term. High BMI at baseline and an increase in BMI predicted a reduced long-term respiratory outcome. LEVEL OF EVIDENCE: 3 Laryngoscope, 131:E307-E313, 2021.
引用
- Sundman J, Browaldh N, Fehrm J, et al. Eight-Year Follow-up of Modified Uvulopalatopharyngoplasty in Patients With Obstructive Sleep Apnea. Laryngoscope. 2020. PMID: 33405253. doi:10.1002/lary.28960
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。